IGF-1 DES: the complete guide
IGF-1 DES is a truncated variant of IGF-1 (des[1-3]) with reduced IGFBP-3 binding affinity, producing a stronger local effect at the injection site due to higher free-IGF-1 concentration.
How IGF-1 DES works
The truncation reduces binding to IGFBP-3, allowing more free IGF-1 to interact with local IGF-1 receptors. Researchers use it for localized anabolic signaling rather than systemic IGF-1 elevation.
Typical IGF-1 DES dosage
Commonly reported research ranges: 30–75 mcg per injection, pre- or post-workout local administration.
Dose should always be individualized. Factors that influence it include bodyweight, research goal, tolerance, and specific compound batch. The information below is educational, not a prescription.
How to reconstitute IGF-1 DES
A widely used reconstitution for a 1 mg vial is 1 ml of bacteriostatic water. With a typical 50 mcg dose this works out to the unit count shown in the calculator below.
Half-life and administration frequency
Approximately 20–30 minutes.
This half-life informs how often IGF-1 DES is typically dosed. Shorter half-lives usually mean more frequent dosing to maintain plasma levels; longer half-lives allow daily, weekly, or less-frequent administration depending on the compound.
Reported side effects
- Hypoglycemia (especially if paired with insulin)
- Injection-site soreness
- Possible tissue-localized effects — limited human safety data
This list reflects effects reported in available literature or user logs. It is not exhaustive. Adverse reactions should be discussed with a qualified clinician.
Common IGF-1 DES stacks
- HGH
- IGF-1 LR3
Storage and handling
Lyophilized: refrigerated. Reconstituted: refrigerated, use within 14 days.
FDA and regulatory status
Not FDA approved. Research use only in the US.
IGF-1 DES clinical trials and evidence
For clinical-trial and primary-literature context, start with the sources below. We prioritize official drug labels, ClinicalTrials.gov records, and PubMed-indexed literature when available.
- IGF-1 variants clinical records — ClinicalTrials.gov
Track your IGF-1 DES protocol on iPhone
Peptide Protocol logs every dose, calculates reconstitution for you, and keeps your full protocol on one calm screen.
See the app →Frequently asked questions
What is IGF-1 DES?
IGF-1 DES is a truncated variant of IGF-1 (des[1-3]) with reduced IGFBP-3 binding affinity, producing a stronger local effect at the injection site due to higher free-IGF-1 concentration.
How does IGF-1 DES work?
The truncation reduces binding to IGFBP-3, allowing more free IGF-1 to interact with local IGF-1 receptors. Researchers use it for localized anabolic signaling rather than systemic IGF-1 elevation.
What is a typical IGF-1 DES dose?
Commonly reported ranges are 30–75 mcg per injection, pre- or post-workout local administration. This is research information, not a recommendation — dosing should be individualized under clinical guidance.
What is the half-life of IGF-1 DES?
Approximately 20–30 minutes. This influences how often it is administered.
How do you reconstitute IGF-1 DES?
A common approach is to add 1 ml of bacteriostatic water to a 1 mg vial. Use the reconstitution calculator for exact unit counts.
What are the side effects of IGF-1 DES?
Hypoglycemia (especially if paired with insulin); Injection-site soreness; Possible tissue-localized effects — limited human safety data.
Is IGF-1 DES FDA approved?
Not FDA approved. Research use only in the US.
Are there clinical trials for IGF-1 DES?
Registered or published clinical-trial sources for IGF-1 DES are listed in the references section below. Evidence depth varies widely by compound, so check the cited trial registries and primary literature before relying on any claim.
References
- IGF-1 DES / des(1-3) IGF-1 literature — National Library of Medicine. Primary research on the truncated IGF-1 variant
- Francis et al. — Des(1-3) IGF-1 activity and IGFBP binding — PubMed. Foundational characterization of des(1-3) IGF-1
- IGF-1 variants clinical records — ClinicalTrials.gov. Limited registered studies
Sources listed above were used to verify the claims on this page. See our editorial policy for how we source information.
Educational use only. Peptide Protocol is an informational tool. Nothing on this page constitutes medical advice. Many peptides are prescription-only or restricted in your jurisdiction. Always consult a licensed healthcare professional before injecting any compound.